Clinical Trials
5
Active:0
Completed:0
Trial Phases
3 Phases
Phase 2:2
Phase 3:1
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (40.0%)Phase 4
2 (40.0%)Phase 3
1 (20.0%)Yiqi Wenjing Prescriptions Preventive Efficacy of Oxaliplatin-induced Peripheral Neuropathy Clinical Trial
Phase 3
- Conditions
- Chemotherapy-induced Peripheral NeuropathyColorectal Cancer
- Interventions
- Drug: Mimetic granules of Yiqi-Wenjing prescriptionsDrug: Huangqi-Guizhi-Wuwu granulesDrug: Danggui-Sini granules
- First Posted Date
- 2020-12-30
- Last Posted Date
- 2020-12-30
- Target Recruit Count
- 360
- Registration Number
- NCT04690283
Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study
Phase 2
- Conditions
- Peripheral T-cell Lymphomas
- Interventions
- Drug: GDPBiological: Endostar
- First Posted Date
- 2015-08-11
- Last Posted Date
- 2015-08-11
- Target Recruit Count
- 60
- Registration Number
- NCT02520219
- Locations
- 🇨🇳
Jiangsu province tumor hospital, Nanjing City, Jiangsu, China
Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research
Phase 4
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- First Posted Date
- 2015-07-31
- Last Posted Date
- 2015-08-04
- Target Recruit Count
- 400
- Registration Number
- NCT02513355
- Locations
- 🇨🇳
Jiangsu Taizhou People's Hospital, Nanjing City, Jiangsu, China
Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma
Phase 4
- Conditions
- Advanced Lung Squamous Carcinoma
- Interventions
- First Posted Date
- 2015-07-31
- Last Posted Date
- 2015-07-31
- Target Recruit Count
- 400
- Registration Number
- NCT02513342
- Locations
- 🇨🇳
Jinling Hospital, Nanjing, Jiangsu, China
🇨🇳The first affiliated hospital of soochow university, Soochow, Jiangsu, China
Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients
Phase 2
- Conditions
- Colon Cancer
- Interventions
- First Posted Date
- 2015-07-28
- Last Posted Date
- 2015-08-03
- Target Recruit Count
- 360
- Registration Number
- NCT02510118
- Locations
- 🇨🇳
Jiege Huo, Nanjing, Jiangsu, China
News
No news found